Arielle Desir

Arielle Desir

Auto-generated profile, based on publicly available information

Arielle Desir

Children's National Hospital

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2026 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
PAPascal Amedro
Pascal Amedro
MAMathieu Andrianoely
Mathieu Andrianoely
PGPauline Gohier
Pauline Gohier
JLJustine Leroux
Justine Leroux
NANathalie Aladjidi
Nathalie Aladjidi
JGJulien Gotchac
Julien Gotchac
Background: Barth syndrome (BTHS) is a rare X-linked mitochondrial disorder characterized by cardiomyopathy, neutropenia, and skeletal myopathy. Elamipretide is a mitochondria-targeting peptide that stabilizes cardiolipin and improves mitochondrial function. While use of this treatment in infants with BTHS has been reported in the United States, no cases have been described outside the US or in older children. Case presentation: We report the first case of a preschool-aged child with genetically confirmed BTHS and advanced heart failure, who was treated with elamipretide under a compassionate use program approved by the French Drug Administration (ANSM). At treatment initiation, this 5-year-old patient presented with severe left ventricular dysfunction (LVEF = 20%) and moderate-to-severe mitral regurgitation. He was dependent on gastrostomy feeding and had been listed for heart transplantation. Subcutaneous elamipretide (10 mg/day) was initiated alongside maximal conventional heart failure therapy. Over six months, LVEF improved to 50%, mitral regurgitation decreased to mild, Ross class improved from IV to I, and substantial gains were observed in functional capacity, nutritional status, and health-related quality of life (HRQoL). The patient returned to full-time school and remained temporarily suspended from the transplant list. Treatment was generally well tolerated. One transient, non-serious episode of abdominal pain with moderate pancreatic enzyme elevation occurred, which resolved without treatment discontinuation. Conclusions: This case suggests that elamipretide may improve cardiac function, exercise tolerance, nutrition, and HRQoL in preschool-aged pediatric BTHS patients, potentially delaying the need for transplantation. Broader pediatric evaluation is warranted. Further strategies, such as youth-tailored hybrid cardiac rehabilitation programs, could complement pharmacological therapy and further optimize outcomes in this population.

30 March 2026 in Health Education & Behavior
Verified
Journal Article
Closed access
AGAlison J. Goldberg
Alison J. Goldberg
RFRey A. Flores
Rey A. Flores
ADArielle Desir
Arielle Desir
MHMakayla Hickmon
Makayla Hickmon
TBTaiylar Ball
Taiylar Ball
JPJennifer A. Pellowski
Jennifer A. Pellowski
Previous research has demonstrated that sexual and reproductive health care providers never or rarely prescribe pre-exposure prophylaxis (PrEP) to cisgender women, despite their perception that HIV burden is high in this population. The present research was therefore designed to explore: (1) providers’ PrEP knowledge and relevant experiences, (2) providers’ willingness to prescribe PrEP to cisgender women, and (3) providers’ perceived barriers to PrEP uptake among cisgender women at the systems/community level, clinician level, and patient level. We conducted semistructured individual interviews with 18 health care providers currently working in a clinical capacity with cisgender women, including Obstetrics/Gynecology (OB/GYN) ( n = 10), Primary Care ( n = 4), Infectious Disease (n = 2), and Other Specialty ( n = 2) providers. Participants practiced in 12 states across the Northeast ( n = 10), West Coast ( n = 4), South ( n = 3), and Midwest ( n = 1) regions of the United States. Interviews were coded using inductive/deductive hybrid thematic analysis. Of the 18 health care providers interviewed, nearly all ( n = 17) expressed willingness to prescribe PrEP. However, among those theoretically willing to prescribe PrEP, fewer than half ( n = 8) had ever prescribed it. When asked open-ended questions about their attitudes and experiences, all providers identified barriers to prescribing PrEP to cisgender women. These barriers fell into four categories: (1) knowledge, messaging, and (mis)information; (2) stigma and/or fear of stigma; (3) characteristics of the medication itself; and (4) accessibility of health care services. We discuss the implications for developing interventions to address the identified implementation gap and increase PrEP access and uptake among cisgender women.

21 July 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
MAMathieu Andrianoely
Mathieu Andrianoely
ADArielle Desir
Arielle Desir
HHHelena Huguet
Helena Huguet
MPMarie-Christine PICOT
Marie-Christine PICOT
MAMarion Audie
Marion Audie
CJCecile Jore
Cecile Jore
Background: The QUALIREHAB (Cardiac Rehabilitation in Youth With Congenital Heart Disease) trial demonstrated the efficacy of a hybrid cardiac rehabilitation model in adolescents and young adults with congenital heart disease. This post hoc mixed‐methods study aimed to identify baseline predictors of clinical improvement and to characterize key components supporting implementation and scalability. Methods: Seventy participants aged 13 to 25 years from the intervention arm were analyzed. Clinical improvement was defined as a clinically meaningful increase in cardiopulmonary fitness (increase in peak oxygen uptake ≥3.5 mL/kg per min) or health‐related quality of life (Pediatric Quality of Life Inventory increase ≥4.3 points). Multivariable logistic regression models identified predictors of clinical improvement. Semistructured interviews with patients and health care professionals explored experiences, barriers, and implementation mechanisms. Results: The absence of prior cardiac surgery or interventional catheterization was independently associated with short‐term improvement in peak oxygen uptake. At 1 year, male sex and lower baseline ventilatory anaerobic threshold were associated with greater peak oxygen uptake improvement. Lower baseline ventilatory anaerobic threshold was also the only predictor of clinically meaningful health‐related quality of life improvement. Qualitative findings highlighted the accessibility and acceptability of the hybrid model but underscored the need for higher‐intensity and more varied exercise modalities, integrated digital tools, continuous psychological support, family involvement, and structured postrehabilitation follow‐up to sustain long‐term benefits. Conclusions: Among treated participants, male sex, absence of prior cardiac surgery, and marked baseline deconditioning were associated with greater clinical improvement, supporting a shift from standardized toward tailored cardiac rehabilitation in congenital heart disease. By addressing key logistical and psychosocial barriers, this scalable framework offers a pragmatic model for routine care implementation and may be transferable to other pediatric chronic conditions. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03690518.